Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331353 · ClinicalTrials.gov registry record · NA
The Allergen Reduction and Child Health Study (ARCHS)
A NA study of Asthma in Children, sponsored by Tulane University.
- Recruiting
- Registry status
- NA
- Development phase
- 290
- Enrollment target
- 1
- Study location
NCT04331353: Recruiting NA study of Asthma in Children, sponsored by Tulane University.
NCT04331353 is a NA study of Asthma in Children that is actively recruiting participants, run by Tulane University. The registered enrollment target is 290 participants, above the 198-participant average among 44 other Asthma in Children trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04331353, a NA study of Asthma in Children, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
- 1
- Study location
Study Summary
The Allergen Reduction and Child Health Study (ARCHS) is a 12-month, two group randomized control trial of children with asthma and who are exposed to cockroaches. Children ages 5 - 17 living in the Greater New Orleans area will be recruited from a variety of clinic and community settings. The overall goal of the study is to improve patient-centered asthma outcomes (asthma symptom days, health care utilization, asthma control and quality of life) by targeting one key allergen - cockroach exposure in the child's home. The investigators propose a simple intervention of insecticidal bait that is low cost, simple to implement, and which is lower toxicity than other forms of pest control. The reduction in the number of cockroaches in the home is an environmental outcome that is patient-centered and is likely to add to its acceptance by families of children with asthma.
Primary Outcome
The number of days with asthma symptoms (chest tightness, cough, wheeze, disrupted sleep, limitations on physical activities) in the previous two weeks.
Conditions Studied
Interventions
- BEHAVIORAL Comparator 1 (tailored approach)
- BEHAVIORAL Comparator 2 (insecticidal bait)
Study Locations (1)
Louisiana
- Tulane University - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2020-11-15 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
What NCT04331353 shows while recruiting
NCT04331353 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, above the 198-participant average among 44 other Asthma in Children trials with a reported enrollment target (46% higher).
The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 2 interventions - of which Comparator 1 (tailored approach) is the first listed.
NCT04331353 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT04331353 about?
NCT04331353 is a clinical study titled "The Allergen Reduction and Child Health Study (ARCHS)". The Allergen Reduction and Child Health Study (ARCHS) is a 12-month, two group randomized control trial of children with asthma and who are exposed to cockroaches. Children ages 5 - 17 living in the Greater New Orleans area will be recruited from a variety of clinic and community settings. The overa...
What is the current status of trial NCT04331353?
This trial is currently recruiting. It is a NA study. The enrollment target is 290 participants. The study started on 2020-11-15. Estimated completion is 2028-04-30.
What conditions does trial NCT04331353 study?
This clinical trial studies the following conditions: Asthma in Children.
What interventions are being tested in trial NCT04331353?
The interventions under investigation include: Comparator 1 (tailored approach) (BEHAVIORAL), Comparator 2 (insecticidal bait) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04331353?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04331353 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04331353's enrollment target sits among peer trials
290 15th of 44 higher than 30 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
-
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
- NCT05056857 · 290 participants
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI